申请人:Chatterjee Sankar
公开号:US20110059959A1
公开(公告)日:2011-03-10
The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.
本发明涉及新型多环分子,可介导酶活性。特别是,这些化合物可以在治疗与PARP、VEGFR2和MLK3酶活性相关的疾病或疾病状态方面发挥作用,包括例如神经退行性疾病、炎症、缺血和癌症。